ETFsXtrackers Harvest CSI300 UCITS ETF 1D
Xtrackers
Xtrackers Harvest CSI300 UCITS ETF 1D
ASHR LSEDistributingLuxembourg
Last close · EUR
10.42EUR
-1.56% · -€0.17
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
ASHRBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- -5.3%
- Sharpe 3Y
- 0.29
- Volatility 1Y
- 13.6%annualised
- Holdings
- 284Fund holdings
Performance
Compare
- ASHR-5.3%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| ASHR | -6.5% | -9.4% | -10.1% | -4.2% | -5.3% | +23.3% | -11.9% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | -6.9% | -14.2% | -20.9% | -20.5% | -21.2% | -52.2% | -83.1% |
Risk and return
Sharpe ratio · 3Y
0.29
Below MSCI World · 1.24- Return p.a.
- +7.0%
- Volatility
- 22.1%
- Max loss
- -28.1%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
ASHR
0.29
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 22.9%
- Holdings
- 284
- As of
- 1KWEICHOW MOUTAI ACNE0000018R83.87%
- 2ZHONGJI INNOLIGHT ACNE100001CY92.74%
- 3CONTEMPORARY AMPEREX TECHNOLOGY ACNE1000036622.74%
- 4PING AN INSURANCE (GROUP) OF CHINACNE000001R842.51%
- 5CHINA MERCHANTS BANK ACNE000001B332.43%
- 6ZIJIN MINING GROUP LTD ACNE100000B242.02%
- 7MIDEA GROUP ACNE100001QQ51.97%
- 8CHINA YANGTZE POWER LTD ACNE000001G871.61%
- 9WUXI APPTEC ACNE1000031K41.57%
- 10INDUSTRIAL BANK ACNE000001QZ71.47%
Countries
Classified 100.0%
China99.9%
- Largest
- 99.9%China
- Top 3
- 100.0%
- Effective number
- 1.01 / HHI
Market cap
Weight vs holdings
22.9%of the fund sits in the top 10 holdings
22.9%30.5%37.9%
WeightHoldings
4015084
- Holdings 1-10
- Holdings 11-50
- Holdings 51-200
- Holdings 201+
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.